Lenzilumab Biosimilar - Research Grade

Human

CSF2

5mg/ml

Human IgG1 Kappa

CHO Cells

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Functional Assays

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Detects human CSF2

Blue ice

Granulocyte-macrophage colony-stimulating factor (CSF2/GM-CSF) is a myeloid growth factor central to inflammation and emergency haematopoiesis, and a frequent subject of immunology research. Our anti-human CSF2 recombinant monoclonal is an unconjugated, non-therapeutic analog of lenzilumab, supplied for research use only (RUO). Engineered to in vivo quality standards, the low-endotoxin preparation is manufactured in scalable milligram (mg) to gram (g) batches for heavy-usage and high-throughput laboratories. Researchers use it in functional assays as a cytokine-neutralisation and control reagent, scaling readily from in vitro screening through to in vivo models of inflammatory and myeloid disease without compromising reproducibility.

P04141

ICH3002

https://www.imgt.org/mAb-DB/